Short answer
Biogen (BIIB) filed an 8-K current report with the SEC on March 11, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Susan H. Alexander, Chief Legal Officer, departing Biogen effective end of May 2026.
Biogen 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Susan H. Alexander, Chief Legal Officer, departing Biogen effective end of May 2026
- CLO search initiated; no interim successor named, creating near-term leadership gap in legal function
- Departure of C-suite legal head adds execution risk during any ongoing regulatory, litigation, or M&A activity
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Biogen 8-K filings
Get the next BIIB 8-K as it lands
Follow BIIB for push alerts, or ask the research agent what this filing means.